← Back to search

Entrada Therapeutics Inc

TRDA · NASDAQ

Research and Development in Biotechnology

ESG Scores

Overall ESG
7.1
Environmental
6.5
Social
4.2
Governance
6.2

Gender Diversity

Female Directors0.25%
CEO GenderMale